The Latest Breaking News from ANTM

Persistently high inflation and other economic uncertainties continue to spook investors. Amid this environment, we think investors should consider investing in companies that offer products and services that face inelastic demand and whose stock provides stable returns in the form of dividends. Therefore, it could be wise to bet on…

According to experts, the Federal Reserve's efforts to control surging inflation by raising interest rates and reducing the size of its balance sheet could eventually tip the nation’s economy into a recession. Furthermore, a plunge in GDP in the first quarter has amplified the risk of a recession this year.…

The near-term market outlook remains cloudy. While the S&P 500 is about 3% above its late-February lows, the Nasdaq and Russell 2000 have already undercut these levels. Below are 3 such stocks that investors should consider buying during this market correction: Anthem (ANTM), Pfizer (PFE), and Builders FirstSource (BLDR).

Anthem (NYSE:ANTM) has outperformed the market over the past 10 years by 10.04% on an annualized basis producing an average annual return of 22.29%. Currently, Anthem has a market capitalization of $127.12 billion.

Analysts have provided the following ratings for Anthem (NYSE:ANTM) within the last quarter:

Anthem Inc (NYSE:ANTM) has reported Q1 FY22 adjusted EPS of $8.25, up 17.7% Y/Y, beating the consensus of $7.81. Operating revenue rose 18% to $37.9 billion, slightly beating the expectations of $37.42 billion, driven by higher premium revenue due to growth in Medicaid & Medicare, MMM & Paramount acquisitions, higher premium rates,…

Analysts have provided the following ratings for Anthem (NYSE:ANTM) within the last quarter:

Anthem (NYSE:ANTM) has observed the following analyst ratings within the last quarter:

Growing concerns over high inflation, escalating sanctions on Russia, and a surge in oil and commodity prices have pushed major benchmark indexes to correction territory. And analysts expect this string of concerns to culminate in a bear market. Therefore, we think it could be wise to bet on Anthem (ANTM),…

The pandemic-driven increase in health awareness and rising chronic diseases should drive the healthcare-plans industry’s growth. However, not all industry participants are well-positioned to gain in the near term. Clover Health (CLOV), with inconsistent financials and growth, is not expected to perform well. Therefore, fundamentally sound stocks in this space—UnitedHealth…

An aging population and rising healthcare spending have been driving the growth of the healthcare plans industry. Therefore, both Anthem (ANTM) and Clover (CLOV) should see an increase in demand for their products. But which one of these stocks is a better buy right now? Read on.